18 Jun 2026

Avacta Academy – Episode 3

Avacta Academy | Therapeutics

05 Jun 2026

Oversubscribed Strategic Equity Fundraise of £9 million

Investors

01 Jun 2026

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

Investors | Therapeutics

29 May 2026

Posting of Annual Report and Notice of AGM

Investors

29 May 2026

Board Director Changes

Investors

19 May 2026

Unaudited Preliminary Results for the Year Ended December 31, 2025

Investors

18 May 2026

May 2026 Science Day video recordings

Investors | Therapeutics

13 May 2026

Notice of Preliminary Results and Investor Presentation

Investors

13 May 2026

Issue of Equity and Total Voting Rights 

Investors

06 May 2026

Avacta presents new comparisons of pre|CISION^® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026

Investors | Therapeutics